Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia
Clinical trial NCT04998201 · COMPLETED
Trial details
- NCT number
- NCT04998201
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-28
- Primary completion
- 2023-02-10
- Enrollment
- 353
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.